FDA says it is launching a Digital Health Center of Excellence within CDRH.
FDA warns Coupler Enterprises about CGMP violations in its manufacturing of finished drugs.
FDA says it will update regulations to clarify the types of evidence it considers when determining the intended use of a medical product.
Federal Register notice: FDA makes available a draft guidance entitled Draft Guidance for Cannabidiol.
Federal Register notice: FDA announces an 11/19 public meeting Webcast entitled CBD and Other Cannabinoids: Sex and Gender Differences in Use and Resp...
FDA alerts health care professionals and patients to a recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma So...
FDA releases its latest batch of Warning Letters that include Coupler Enterprises and HNC Products.
The Washington Post reports that FDA will issue a new guidance for Covid-19 vaccines that will tighten emergency authorization standards and most like...